These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 26099683)
1. Modeling hepatitis B virus infection, immunopathology and therapy in mice. Cheng L; Li F; Bility MT; Murphy CM; Su L Antiviral Res; 2015 Sep; 121():1-8. PubMed ID: 26099683 [TBL] [Abstract][Full Text] [Related]
2. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation. Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488 [TBL] [Abstract][Full Text] [Related]
3. Animal models of HBV infection. Dandri M; Petersen J Best Pract Res Clin Gastroenterol; 2017 Jun; 31(3):273-279. PubMed ID: 28774409 [TBL] [Abstract][Full Text] [Related]
4. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections. Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055 [TBL] [Abstract][Full Text] [Related]
5. Small animal model systems for studying hepatitis B virus replication and pathogenesis. Dandri M; Lutgehetmann M; Volz T; Petersen J Semin Liver Dis; 2006 May; 26(2):181-91. PubMed ID: 16673296 [TBL] [Abstract][Full Text] [Related]
6. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. Morrey JD; Korba BE; Sidwell RW Antivir Ther; 1998; 3(Suppl 3):59-68. PubMed ID: 10726056 [TBL] [Abstract][Full Text] [Related]
7. Humanized chimeric mouse models of hepatitis B virus infection. Sun S; Li J Int J Infect Dis; 2017 Jun; 59():131-136. PubMed ID: 28408253 [TBL] [Abstract][Full Text] [Related]
8. Experimental in vitro and in vivo models for the study of human hepatitis B virus infection. Allweiss L; Dandri M J Hepatol; 2016 Apr; 64(1 Suppl):S17-S31. PubMed ID: 27084033 [TBL] [Abstract][Full Text] [Related]
9. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Yang PL; Althage A; Chung J; Chisari FV Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13825-30. PubMed ID: 12374864 [TBL] [Abstract][Full Text] [Related]
10. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV. Meuleman P; Leroux-Roels G Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933 [TBL] [Abstract][Full Text] [Related]
11. Animal models for the study of hepatitis B virus infection. Guo WN; Zhu B; Ai L; Yang DL; Wang BJ Zool Res; 2018 Jan; 39(1):25-31. PubMed ID: 29511142 [TBL] [Abstract][Full Text] [Related]
12. Liver immune-pathogenesis and therapy of human liver tropic virus infection in humanized mouse models. Bility MT; Li F; Cheng L; Su L J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1(0 1):120-4. PubMed ID: 23855307 [TBL] [Abstract][Full Text] [Related]
13. Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies. Isorce N; Lucifora J; Zoulim F; Durantel D Antiviral Res; 2015 Oct; 122():69-81. PubMed ID: 26275801 [TBL] [Abstract][Full Text] [Related]
14. Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the "magic bullet" to kill cccDNA. Zhang E; Kosinska A; Lu M; Yan H; Roggendorf M Antiviral Res; 2015 Nov; 123():193-203. PubMed ID: 26476376 [TBL] [Abstract][Full Text] [Related]
15. Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection. Chuai X; Wang W; Chen H; Deng Y; Wen B; Tan W Antiviral Res; 2014 Jan; 101():68-74. PubMed ID: 24239872 [TBL] [Abstract][Full Text] [Related]
16. Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions. Liu Y; Maya S; Ploss A Viruses; 2021 Apr; 13(5):. PubMed ID: 33924793 [TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection. Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082 [TBL] [Abstract][Full Text] [Related]
18. The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. Ilan E; Burakova T; Dagan S; Nussbaum O; Lubin I; Eren R; Ben-Moshe O; Arazi J; Berr S; Neville L; Yuen L; Mansour TS; Gillard J; Eid A; Jurim O; Shouval D; Reisner Y; Galun E Hepatology; 1999 Feb; 29(2):553-62. PubMed ID: 9918935 [TBL] [Abstract][Full Text] [Related]
19. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes. Tabuchi A; Tanaka J; Katayama K; Mizui M; Matsukura H; Yugi H; Shimada T; Miyakawa Y; Yoshizawa H J Med Virol; 2008 Dec; 80(12):2064-8. PubMed ID: 19040280 [TBL] [Abstract][Full Text] [Related]
20. Animal model for study of human hepatitis viruses. Chayama K; Hayes CN; Hiraga N; Abe H; Tsuge M; Imamura M J Gastroenterol Hepatol; 2011 Jan; 26(1):13-8. PubMed ID: 21175788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]